{"entity":{"id":"1958","kind":"year","name":"1958 in oncology","aka":["1958"],"tldr":"Everything OnCo dates to 1958: 8 entries, 4 landmarks, 2 technologies, 1 approval and 1 company founded. Each line links to the record it was read from, so the year is a view of the corpus rather than a second copy of it.","summary":"8 dated entries in OnCo fall in 1958: 4 landmarks, 2 technologies, 1 approval and 1 company founded.\n\nOf those, 8 to the year only. Most of the corpus dates a fact to the year, because that is what the source it was read from gives; regulatory events and the readout calendar are the parts that carry a full date.\n\nEverything on this page is generated from the other records. It holds no fact of its own, and it changes when they do.","asOf":"2026-09-25","links":[],"tags":[],"related":["1957","1959"],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["Generated from every dated field in the corpus, not written by hand. The groups and the fields behind them are listed in src/lib/year-groups.ts; the reader is src/lib/years.ts."],"year":1958,"events":[{"group":"approval","date":"1958","precision":"year","title":"Dexamethasone approved in US","note":"Palliative management of leukaemias and lymphomas; inflammatory and allergic conditions","from":"dexamethasone","refs":[]},{"group":"company","date":"1958","precision":"year","title":"NSABP Foundation founded","note":"Pittsburgh, PA","from":"nsabp-foundation","refs":[]},{"group":"history","date":"1958","precision":"year","title":"Bouroncle describes 'leukemic reticuloendotheliosis'","note":"Hairy cell leukaemia","from":"hairy-cell-leukemia","refs":[]},{"group":"history","date":"1958","precision":"year","title":"Denis Burkitt describes the jaw tumour of African children","note":"Burkitt lymphoma. Later maps its distribution to the malaria belt.","from":"burkitt-lymphoma","refs":[]},{"group":"history","date":"1958","precision":"year","title":"Melphalan introduced; melphalan-prednisone standard for 40 years","note":"Multiple myeloma","from":"multiple-myeloma","refs":["cytotoxic-chemotherapy"]},{"group":"history","date":"1958","precision":"year","title":"Oestrogen receptor discovered (Jensen)","note":"HR-positive / HER2-negative breast cancer. Basis for predicting hormone responsiveness.","from":"breast-hr-positive","refs":[]},{"group":"technology","date":"1958","precision":"year","title":"Body-surface-area dosing","note":"First use in humans or first approval, as the technology record states it.","from":"body-surface-area-dosing","refs":[]},{"group":"technology","date":"1958","precision":"year","title":"Isolated limb perfusion and infusion","note":"First use in humans or first approval, as the technology record states it.","from":"isolated-limb-perfusion","refs":[]}]},"route":"/years/1958/","neighbours":{"year":[{"id":"1957","kind":"year","name":"1957 in oncology","route":"/years/1957/"},{"id":"1959","kind":"year","name":"1959 in oncology","route":"/years/1959/"}]}}